APR 24, 2018 06:15 AM PDT

A Vaccine for Bath Salts Abuse

WRITTEN BY: Kara Marker

You may think of crystal meth when you read “the poor man’s cocaine,” but bath salts are another drug that people turn to when they can’t afford crack. A new University of Arkansas for Medical Sciences study shows the possibility for a vaccine to prevent recovering drug users of bath salts from experiencing a relapse.

Bath salts, also known as synthetic cathinones, are a type of “new psychoactive substance” (NPS) of concern to public health officials. Natural cathinone comes from the khat plant from East Africa and southern Arabia, where natives chew the leaves to experience the stimulant effects from the drug. Synthetic versions of cathinone are particularly dangerous though, because they are much more potent than the naturally occurring version.

Synthetic cathinones come in the form of white or brown crystal-like powder, marketed as a less expensive version of stimulants like methamphetamine and cocaine. The drug can be swallowed, snorted, smoked, or injected. Like other drugs, abuse of synthetic cathinones includes the risk of overdose and life-threatening side effects like organ failure. The new vaccine could block the effect of synthetic cathinones on the brain, helping recovering drug users during a relapse.

"Because the chemical structures of these illegal drugs are often changed to evade drug laws, we decided it was important to develop a single vaccine that will be effective against more than one medically dangerous synthetic cathinone," explained doctoral student Samantha McClenahan.

The vaccine targets two synthetic cathinones: methylenedioxypyrovalerone (MDPV) and alpha-pyrrolidinovalerophenone (alpha-PVP). In a rodent model of drug abuse, the vaccine successfully triggered the production of antibodies that attach to MDPV and alpha-PVP in the blood stream. This attachment decreases the stimulant effects of MDPV for months compared to unvaccinated rats.

McClenahan and others are hoping to create a vaccine that reduces the stimulant effects of the drug for at least six months, preferably up to one year to be used as a “long-lasting aid to the rehabilitation process.” Researchers will also study further the vaccine’s ability to prevent MDPV from infiltrating the brain and heart to simultaneously prevent the drug’s stimulant effects and potentially lethal side effects.

"It would likely help reduce drug concentrations in critical organs and reduce or eliminate the rewarding effect of the drug,” McClenahan said. “This could improve the chances of an individual remaining in rehabilitation treatment, which might increase the likelihood of a successful outcome."

Sources: National Institute on Drug Abuse, Experimental Biology 2018

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 05, 2018
Health & Medicine
JUL 05, 2018
Is Testing Everyone for Hep C Necessary?
Cases of Hepatitis C, known as Hep C or HCV, are on the rise. In the United States, the CDC reports that there were approximately 3,000 new cases of hepati...
AUG 27, 2018
Cell & Molecular Biology
AUG 27, 2018
Stopping Cell Suicide
Chronic inflammation has been linked to many diseases and can trigger cell death....
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Combination Therapy for Advanced Melonoma
According to a research study led by UCLA, a bacteria-like agent used in combination with an immunotherapeutic drug may help patients survive longer with a...
SEP 25, 2018
Videos
SEP 25, 2018
Heal Faster
Active patient vs passive patient...
SEP 26, 2018
Immunology
SEP 26, 2018
What Superbug? A New Antibiotic Contender
Scientists from a biotechnology corporation, Genentech, have altered a protein that blocks a signaling pathway in gram-negative bacteria to engineer a new antibiotic, currently called G0775,...
OCT 04, 2018
Videos
OCT 04, 2018
Why Do We Have Nightmares With a Fever?
Fever is the body’s response to a threat. When some viruses or bacteria try to enter the body, an immune response begins that can include a sharp ris...
Loading Comments...